The GLP-1 CVD outcome trials a) Elixa (Lexisenatide) b) Leader (Liraglutide) c) Sustain-6 (Semaglutide) d) Exscel (Weekly Exenatide) e) Harmony (Albiglutide) f) Rewind (Dulaglutide) g) Pioneer 6 (Oral Semaglutide) Elixa Study (Evaluation of Lixisenatide) In ELIXA, the investigational GLP-1 receptor agonist, lixisenatide, neither reduced nor increased cardiovascular events compared with placebo
Kraljevic S, Stambrook PJ, Pavelic K
This app allows you to track your alcohol intake so youre aware of how much you drink and when
By gradually increasing the tirzepatide dosage while staying on a stable dose of metformin, the body has time to adapt
Examples include 16 : Endometrial uterine polyps Uterine fibroids (leiomyomata) Endometriosis Congenital uterine malformations Intrauterine scarring and adhesions (synechiae), also known as Asherman syndrome 22 Abnormalities of the cervix, whether congenital or acquired through surgery or dysplasia (a precancerous condition), as well as decreased cervical mucous, can disrupt sperm progression and prevent fertilization
